Abstract:The antagonistic pleiotropy hypothesis is a well-known evolutionary theory to explain the aging process. It proposes that while a particular gene may possess beneficial effects during development, it can exert deleterious properties in the aging process. The aryl hydrocarbon receptor (AhR) has a significant role during embryogenesis, but later in life, it promotes several age-related degenerative processes. For instance, AhR factor (i) controls the pluripotency of stem cells and the stemness of cancer stem cells, (ii) it enhances the differentiation of embryonal stem cells, especially AhR signaling modulates the differentiation of hematopoietic stem cells and progenitor cells, (iii) it also stimulates the differentiation of immunosuppressive Tregs, Bregs, and M2 macrophages, and finally, (iv) AhR signaling participates in the differentiation of many peripheral tissues. On the other hand, AhR signaling is involved in many processes promoting cellular senescence and pathological processes, e.g., osteoporosis, vascular dysfunction, and the age-related remodeling of the immune system. Moreover, it inhibits autophagy and aggravates extracellular matrix degeneration. AhR signaling also stimulates oxidative stress, promotes excessive sphingolipid synthesis, and disturbs energy metabolism by catabolizing NAD + degradation. The antagonistic pleiotropy of AhR signaling is based on the complex and diverse connections with major signaling pathways in a context-dependent manner. The major regulatory steps include, (i) a specific ligand-dependent activation, (ii) modulation of both genetic and non-genetic responses, (iii) a competition and crosstalk with several transcription factors, such as ARNT, HIF-1α, E2F1, and NF-κB, and (iv) the epigenetic regulation of target genes with binding partners. Thus, not only mTOR signaling but also the AhR factor demonstrates antagonistic pleiotropy in the regulation of the aging process.

The Role of AhR in the Hallmarks of Brain Aging: Friend and Foe

Aryl hydrocarbon receptor: Linking environment to aging process in elderly patients with asthma

The aryl hydrocarbon receptor pathway: a linking bridge between the gut microbiome and neurodegenerative diseases

The aryl hydrocarbon receptor promotes aging phenotypes across species

Aryl Hydrocarbon Receptor in Post-Mortem Hippocampus and in Serum from Young, Elder, and Alzheimer’s Patients

Aryl hydrocarbon receptor (AhR) reveals evidence of antagonistic pleiotropy in the regulation of the aging process

Aryl hydrocarbon receptor (AhR) impairs circadian regulation: Impact on the aging process

Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis

Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases

Aging, sex, metabolic and life experience factors: contributions to neuro-inflammaging in Alzheimer's disease research

The emerging roles of AhR in physiology and immunity

The Ah Receptor: Adaptive Metabolism, Ligand Diversity, and the Xenokine Model

Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals

Role of the Aryl Hydrocarbon Receptor in Environmentally Induced Skin Aging and Skin Carcinogenesis

Role of the central nervous system in cell non-autonomous signaling mechanisms of aging and longevity in mammals

Aging Increases Markers of Inflammation and Alters Brain‐Gut Interactions

The Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer's Disease

The mechanisms, hallmarks, and therapies for brain aging and age-related dementia

An introduction to the molecular basics of aryl hydrocarbon receptor biology

Peripheral immune system in aging and Alzheimer’s disease

AH RECEPTOR SIGNALING PATHWAYS